Completed PHASE4 INTERVENTIONAL 3-arm NCT01225952

Three Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction

A Three Arm Prospective Clinical Evaluation of Three FDA-approved Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction

Sponsor: Bausch & Lomb Incorporated

Conditions Cataract

Interventions AMO Tecnis Multifocal Crystalens AO ReSTOR 3.0

Updated 6 times since 2017 Last updated: Dec 11, 2012 Started: Jul 31, 2010 Primary completion: Jun 30, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01225952, this PHASE4 trial focuses on Cataract and remains completed. Sponsored by Bausch & Lomb Incorporated, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bausch & Lomb Incorporated

Data source: Bausch & Lomb Incorporated

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Makati City, Philippines